Shreeyashi Ojha

Pluri has collaborated with Bar-Ilan University to develop placental mucosal associated invariant (MAIT) T-cells for solid tumors. We spoke to the company’s spokesperson to find out more.

Ardena bolsters bioanalytical capacity with Netherlands lab construction

Sterling has invested over £10 million ($12.8 million) to expand its Deeside, Wales facility for antibody-drug conjugate (ADC) manufacturing.

Biotechnology giant Thermo Fisher Scientific is constructing a bioprocess design facility in Hyderabad, Telangana, India.

Experts call for better analytics, customization, R&D, and strategic investments as cell and gene therapies struggle with funding challenges and complex manufacturing needs.

The 350,000 square-foot plant will produce messenger RNA (mRNA) needed for commercial phase manufacturing of vaccines and oligonucleotides.

Danish pharma giant Novo Nordisk will use Ascendis’ TransCon platform to produce its once-monthly GLP-1 receptor agonist candidate.

Bioprocess vendor Repligen aims to launch “disruptive solutions” for new modalities in 2025.

The contract development manufacturing organization (CDMO) is adding two 1,200-L production suites at its Ibex biopark facility in Visp, Switzerland.

The plant will manufacture filtration products to meet the growing demands for advanced therapies, the firm said.